Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Gilead Sciences, Inc.
(NQ:
GILD
)
56.30
USD
+1.34 (+2.44%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Gilead Sciences, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Profitable Trading Secrets Revealed in GILD, NWSA, RF and MTG
May 18, 2013
from
Marketwired News Releases
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20
May 17, 2013
from
Business Wire News Releases
UBS Survey Shows Signs of Strength for Gilead's (GILD) TAF
May 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8350777 for the full story.
Read More
from
StreetInsider.com News Articles
Analyst Moves: NOC, GM, GILD
May 17, 2013
This morning, Credit Suisse increased its price target on shares of Northrop Grumman (NOC) to $78 as additional buybacks will boost the stock. In the report, Credit Suisse also increased its EPS...
Read More
category
Stocks
from
Market News Video
AbbVie (ABBV) Has Plenty More Tricks Up Its Sleeve - Barron's
May 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8349940 for the full story.
Read More
from
StreetInsider.com News Articles
Lightning Round: Starbucks, Gilead & More
May 16, 2013
Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.
Read More
category
Lightning Round
,
Starbucks Corp
,
Dominion Resources Inc
, and 10 more.
from
CNBC.com News
Gilead anuncia datos de respuesta del estudio de Fase 2 de idelalisib para leucemia linfática crónica no tratada con anterioridad
May 16, 2013
from
Business Wire Spanish
Strategy Behind Our Success, We Get in Early: GILD, MCP, GM and DF
May 16, 2013
from
Marketwired News Releases
With 'Cell Death' Drugs, Bristol-Myers May Win No Matter What
May 15, 2013
A new class of anti-cancer drugs that allow the immune system to attack cancer cells are generating considerable excitement among patients, doctors, and investors. New results being released ahead of...
Read More
category
NYSE:JNJ
,
NYSE:MRK
,
NASDAQ:PCYC
, and 2 more.
from
Forbes Real Time
Gilead Offers Response Data from Phase 2 Study of Idelalisib
May 15, 2013
Gilead Sciences, Inc. (Nasdaq: GILD ) today announced results from a Phase 2 study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted, oral inhibitor of PI3K delta,...
Read More
category
Benzinga
,
News
,
FDA
, and 1 more.
from
Latest Articles from Benzinga.com
Gilead Announces Response Data from Phase 2 Study of Idelalisib for Previously Untreated Chronic Lymphocytic Leukemia
May 15, 2013
from
Business Wire News Releases
Experimental Gilead drug effective in early-stage leukemia trial
May 15, 2013
May 15 (Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray into...
Read More
category
companyNews
from
Reuters: Company News
Medical Stocks Gaining Momentum (GILD, HALO, AFFY, AVEO)
May 15, 2013
New York, NY -- (SBWIRE) -- 05/15/2013 -- Gilead Sciences, Inc. (NASDAQ:GILD) shares rose 0.43% $ 56.49 while trading in range of $ 55.09 – 57.10 with average volume 12.93 million shares. GILD price to...
Read More
from
SBWire - Latest Press Releases
Griffin's Blue Ridge Capital Enters CBS (CBS), Citigroup (C), Netflix (NFLX); Exits Apple (AAPL)
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8340860 for the full story.
Read More
from
StreetInsider.com News Articles
In the Know, Smart Investing in FCX, GILD, AIG and BMY
May 15, 2013
from
Marketwired News Releases
Jim Cramer's 5 Investing Sweet Spots
May 14, 2013
Jim Cramer often advocates themes in the market. These are big picture ideas that he believes will lift the fortunes of companies and by proxy their stocks. Following are 5 themes that he likes right...
Read More
category
Regeneron Pharmaceuticals Inc
,
EOG Resources Inc
,
ENSCO International Incorporated
, and 14 more.
from
CNBC.com News
NASDAQ Gainers Watch List: Tranzyme, Inc. (NASDAQ:TZYM), ICON Public Limited Company (NASDAQ:ICLR), and Gilead Sciences Inc. (NASDAQ:GILD) Added to Growing Stock Report's NASDAQ Gainers Watch List.
May 14, 2013
New York, NY -- (SBWIRE) -- 05/14/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Tranzyme, Inc. (NASDAQ:TZYM), ICON Public Limited Company (NASDAQ:ICLR), and Gilead...
Read More
from
SBWire - Latest Press Releases
4 Stocks Moves Up in Market Cap Rank (BAC, TSLA, LVS, GILD)
May 14, 2013
New York, NY -- (SBWIRE) -- 05/14/2013 -- Bank of America Corp (NYSE:BAC) shares increased 2.43% to $13.30. Bank of America Corp has agreed to pay $1.6 billion in cash to MBIA Inc and will receive the...
Read More
from
SBWire - Latest Press Releases
Gilead Sciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, May 15
May 14, 2013
from
Business Wire News Releases
Gilead Sciences, Inc. (GILD) Call Traders Target New Highs
May 14, 2013
Calls were the options of choice on Gilead Sciences, Inc. (NASDAQ:GILD) yesterday, with roughly 27,000 contracts crossing the tape during the course of the session...( Read More )
Read More
category
GILD
from
SchaeffersResearch.com Daily Market Blog
Reveal Insider Trading in J.C. Penney, Gilead Sciences, Chesapeake Energy, Annaly Capital Management, Endo Health Solutions, and Zynga
May 14, 2013
from
PR Newswire
Special Situation Coming Soon, a Look Inside MS, GILD, FITB and WFR
May 14, 2013
from
Marketwired News Releases
Theravance Inc. (NASDAQ:THRX), Gilead Sciences Inc. (NASDAQ:GILD), and Unilife Corporation (NASDAQ:UNIS) Added to Equity Profile Report's NASDAQ Gainers Watch List.
May 13, 2013
Wilmington, DE -- (SBWIRE) -- 05/13/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Theravance Inc. (NASDAQ:THRX), Gilead Sciences Inc. (NASDAQ:GILD), and Unilife...
Read More
from
SBWire - Latest Press Releases
Midday Movers: GILD, BSX, AES & More
May 13, 2013
Take a look at some of Monday's midday movers:
Read More
category
AES Corp
,
Yum! Brands Inc
,
Advanced Micro Devices Inc
, and 10 more.
from
CNBC.com News
Noteworthy ETF Outflows: IYH, GILD, ESRX, MDT
May 13, 2013
Symbols mentioned in this story: IYH, GILD, ESRX, MDT Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Read More
category
ETFs
from
ETF Channel
Highlights on Options Trading for Gilead Sciences
May 13, 2013
NEW YORK (AVAFIN) -- Options traders were heavily trading call contracts during the last ...
Read More
from
AVAFIN
Secrets to Making Money in WCRX, T, GILD and IBM
May 11, 2013
from
Marketwired News Releases
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences...
Read More
category
Regeneron Pharmaceuticals
,
amgen
,
Benzinga
, and 35 more.
from
Latest Articles from Benzinga.com
The Straight Truth, Investing in OXY, LULU, GILD and V
May 10, 2013
from
Marketwired News Releases
Gilead Sciences Shares Up 89.8% Since SmarTrend's Buy Recommendation (GILD)
May 10, 2013
from
Comtex SmarTrend® News Briefs
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here